Silybum marianum (L.) Gaertn. in Veterinary Medicine: Phytochemical Diversity, Hepatoprotective Mechanisms, Bioavailability, and Species-Specific Applications

Silybum marianum (L.) Gaertn. represents a phytogenic resource of growing interest in veterinary medicine and animal production because of the hepatoprotective, antioxidant, anti-inflammatory, metabolic, and antifibrotic effects attributed to silymarin and its major flavonolignans. This critical narrative review synthesizes literature published between 1 January 2016 and 3 September 2026 on phytochemical variability, biological and hepatoprotective mechanisms, bioavailability, safety, and veterinary applications. A targeted search was conducted in PubMed/MEDLINE, Web of Science Core Collection, and Scopus for relevant peer-reviewed publications. Experimental evidence indicates interconnected effects on redox homeostasis, inflammatory signaling, mitochondrial function, lipid metabolism, and fibrogenesis. The largest body of direct applied evidence derives from poultry studies, whereas fewer studies are available in swine and aquaculture, and evidence in ruminants, equids, and companion animals remains limited. Interpretation across studies is constrained by heterogeneity in plant material, chemotype, extraction procedures, flavonolignan composition, dose expression, and formulation. The low oral bioavailability of silybin has stimulated the development of micellar, phospholipid-based, nanocrystalline, nanoparticulate, and co-crystal delivery systems. Future research should prioritize well-characterized preparations, species-specific pharmacokinetic and dose–response studies, long-term safety assessment, residue evaluation in food-producing animals, and validation under clinically and commercially relevant conditions.

Authors

Institutions

Publication Details

Journal
Life
Published
2026-11-12
DOI
https://doi.org/10.3390/life16111907
Primary Topic
Silymarin and Mushroom Poisoning
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Silybum marianum (L.) Gaertn. in Veterinary Medicine: Phytochemical Diversity, Hepatoprotective Mechanisms, Bioavailability, and Species-Specific Applications

Jelena Savici, Romeo Teodor Cristina, Флорин Муселин, Eugenia Dumitrescu et al.
Life
Silymarin and Mushroom Poisoning
article

Silybum marianum (L.) Gaertn. in Veterinary Medicine: Phytochemical Diversity, Hepatoprotective Mechanisms, Bioavailability, and Species-Specific Applications

Jelena Savici, Romeo Teodor Cristina, Флорин Муселин, Eugenia Dumitrescu, Diana Brezovan, Bogdan Alexandru Florea, Maria-Larisa Ardelean (căs.Rusu), Alexandru Octavian Doma
article en

Abstract

Silybum marianum (L.) Gaertn. represents a phytogenic resource of growing interest in veterinary medicine and animal production because of the hepatoprotective, antioxidant, anti-inflammatory, metabolic, and antifibrotic effects attributed to silymarin and its major flavonolignans. This critical narrative review synthesizes literature published between 1 January 2016 and 3 September 2026 on phytochemical variability, biological and hepatoprotective mechanisms, bioavailability, safety, and veterinary applications. A targeted search was conducted in PubMed/MEDLINE, Web of Science Core Collection, and Scopus for relevant peer-reviewed publications. Experimental evidence indicates interconnected effects on redox homeostasis, inflammatory signaling, mitochondrial function, lipid metabolism, and fibrogenesis. The largest body of direct applied evidence derives from poultry studies, whereas fewer studies are available in swine and aquaculture, and evidence in ruminants, equids, and companion animals remains limited. Interpretation across studies is constrained by heterogeneity in plant material, chemotype, extraction procedures, flavonolignan composition, dose expression, and formulation. The low oral bioavailability of silybin has stimulated the development of micellar, phospholipid-based, nanocrystalline, nanoparticulate, and co-crystal delivery systems. Future research should prioritize well-characterized preparations, species-specific pharmacokinetic and dose–response studies, long-term safety assessment, residue evaluation in food-producing animals, and validation under clinically and commercially relevant conditions.

LifeVol. 16(11)
Univesity of Life Science "King Mihai I" from Timisoara (RO)
Zero hunger, Good health and well-being
Silymarin and Mushroom Poisoning
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon